Research
Scientific articles on peptide research, documentation, purity, and traceability.
Alpha Research
Growth hormone
CJC-1295 with DAC: GHRH Receptor Binding, Albumin Conjugation Mechanism, and Extended Half-Life Pharmacokinetics
Technical analysis of CJC-1295/DAC: covalent albumin conjugation mechanism via Drug Affinity Complex group, extended release kinetics (t½ ~6–8 days), GHRH-R receptor activation, and GH/IGF-1 AUC data from human clinical studies.
Alpha Research
Growth hormone
Ipamorelin: GHS-R1a Binding Selectivity, Pulsatile GH Secretion, and Pharmacokinetic Profile
Clinical analysis of ipamorelin as a selective GHS-R1a agonist: cAMP/PKA signaling mechanism in pituitary somatotrophs, GH pulse architecture, pharmacokinetic profile (t½ ~2h), and IGF-1 response data from preclinical models.
Alpha Research
Recovery
BPC-157 Preclinical Data Compendium: Key Rodent Studies, Dosing Parameters, and Endpoint Measurements
Structured compendium of BPC-157 preclinical data: study designs, dosing parameters, functional endpoints in gastrointestinal, tendon, and muscle models, and molecular data on VEGFR2, FAK, NF-κB, and MAPK/ERK from published rodent literature.
Alpha Research
Recovery
Peptides and Chronic Inflammation: NF-κB, TNF-α, IL-6 Modulation in Preclinical Models
Mechanistic review of KPV, BPC-157, and GHK-Cu as modulators of NF-κB, STAT3, TNF-α, and IL-6 signaling in chronic inflammation models: quantified endpoint data, pharmacokinetics, and purity requirements for reproducible outcomes.
Alpha Research
Recovery
Peptide-Induced Angiogenesis: VEGF Upregulation, HIF-1α, and Endothelial Cell Migration Mechanisms
Analysis of the angiogenic signaling of BPC-157, TB-500, and GHK-Cu: HIF-1α stabilization, VEGFR2 upregulation, MAPK/ERK and PI3K/Akt activation in endothelial cells, and quantified tube formation and vessel density data from preclinical models.
Alpha Research
Recovery
Peptides in Musculoskeletal Repair Research: Tendon, Muscle, and Ligament Models
Mechanistic review of BPC-157, TB-500, and GHK-Cu in preclinical musculoskeletal repair models: FAK/VEGFR2 signaling, actin sequestration, TGF-β1/MMP remodeling, and rodent pharmacokinetic parameters.
Alpha Research
Recovery
KPV and IBD Models: NF-κB Inhibition, MC1R Signaling, and Intestinal Epithelial Repair
Mechanistic analysis of KPV in intestinal inflammation models: NF-κB inhibition via MC1R, NLRP3 inflammasome suppression, epithelial barrier restoration, and quantified endpoint data from DSS colitis rodent models.
Alpha Research
Fundamentals
Technical Glossary: Peptide Chemistry, Pharmacokinetics, and Research Documentation Terms
Technical reference of essential terms for researchers working with synthetic peptides: precise definitions of analytical parameters (NPC, HPLC-UV, ESI-MS, LAL), pharmacological concepts (Ki, EC50, Bmax, kon/koff), synthesis terminology (SPPS, Fmoc, resin loading), and lot documentation parameters required in preclinical protocols.
Alpha Research
Fundamentals
Clinical-Grade Peptide Supply Chains: Documentation, Traceability, and CoA Standards
Analysis of criteria defining a research-grade peptide supply chain: lot documentation standards, required analytical methods (HPLC, MS, LAL), endotoxin control, cold-chain custody, and minimum elements of a defensible certificate of analysis for preclinical and regulatory environments.
Alpha Research
Fundamentals
2026 Research Frontiers: GLP-1/GIP Triple Agonists, Mitochondrial Peptides, and Senolytic Peptide Agents
Analysis of the three most active areas of peptide research in 2026: triple incretin receptor agonism (GLP-1R/GIPR/GCGR) with retatrutide as the clinical prototype, mitochondrial peptidomics with elamipretide and MOTS-c as biogenesis agents, and senolytic peptides based on FOXO4-DRI sequences for senescent cell elimination.
Alpha Research
Fundamentals
HPLC Purity, Mass Spectrometry Identity, and Lot Documentation Standards in Research Peptides
Technical review of analytical methods defining research peptide quality: HPLC-UV/DAD chromatography at 214 nm, identity confirmation by ESI-MS or MALDI-TOF, endotoxin assays, net peptide content (NPC), and minimum CoA parameters required for reproducible preclinical protocols.
Alpha Research
Fundamentals
Synthetic vs Endogenous Peptides: Stability, Selectivity, and Research Utility
Comparative analysis of endogenous peptides and their synthetic analogues: differences in proteolytic resistance, receptor affinity and selectivity, pharmacokinetic profile, and analytical purity control that determine the advantage of synthetic analogues in reproducible preclinical research.